The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
In vitro Investigation of Radiotherapy along with Gemcitabine Loaded PEG Gold Nanoparticles Against MCF-7 Breast Cancer Cells
Open accessAbstract
Background: Breast cancer is one of the major causes of cancer death in women. Usually, surgery, chemotherapy, and radiotherapy are commonly used in the treatment of breast cancer, but these methods have significant side effects and low survival rates. By developing combination therapies, side effects can be reduced so that therapeutic efficacy is maintained. The aim of this study was to examine the effects of radiotherapy combined with chemotherapy using combined gem and gold nanoparticle for the treatment of breast cancer. Materials and Methods: In this study, PEGylated gold nanoparticles (PEG-GNPs) were synthesized and loaded with an anticancer agent, gemcitabine (Gem-PEG-GNPs). Then, GNPs, PEG-GNPs, and Gem-PEG-GNPs were investigated using several techniques, including UV-Vis, FTIR, DLS, and TEM analysis. After that, the efficacy of the synthesized nanoparticles for chemoradiotherapy was evaluated through in vitro experiments. Results: The prepared Gem-PEG-GNPs act as radiosensitizers and nanocarrier, which increases the effectiveness of radio chemotherapy and reduces side effects. Combining Gem-PEG-GNPs with X-ray irradiation increased apoptosis and decreased survival rates of MCF-7 cells. When Gem-PEG-GNPs and radiation were combined, a significant synergistic effect was observed compared to the effect of radiation alone. Conclusion: Gem-PEG-GNPs can have the potential of an effective and radiosensitizing drug delivery agent against breast cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies further describe catalytic or redox-responsive systems capable of sustaining oxidative injury through glutathione depletion and endogenous hydroxyl radical generation [31,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the overall magnitude of radiotherapy enhancement is not determined by atomic number alone but is also influenced by nanoparticle composition, size, surface functionalization, intracellular localization, and other physicochemical and biological characteristics [17,21,31,87].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experimental studies further support these mechanisms, with gold nanoparticles demonstrating dose enhancement factors of approximately 1.3 under kilovoltage irradiation in breast cancer models, while more advanced multifunctional systems achieve sensitizer enhancement ratios exceeding 1.5 through combined oxidative and intracellular damage pathways [14,23,87,89].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In catalytic and chemodynamic systems, sustained intracellular ROS production can maintain oxidative stress beyond the initial irradiation event, promoting persistent DNA damage, delaying repair processes, and increasing the probability of irreversible reproductive cell death [17,31,68,77,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This effect may be further enhanced by stimulus-responsive nanoplatforms capable of depleting intracellular antioxidants such as glutathione or exploiting endogenous hydrogen peroxide to continuously generate reactive species [17,19,21,31,53,68,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180 · cited 1×
“[49] In addition, due to the EPR effect, the nanoparticle system increases drug accumulation at the tumor site.”
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438 · cited 1×
“[51,52] As a result, Gem‑PEG‑GNPs with a hydrodynamic size of 37.9 nm have low permeability for normal capillaries and cause higher accumulation in tumor due to the EPR effect.”
InfluentialAcidity Generated by the Tumor Microenvironment Drives Local Invasion
Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., Bailey, K., Balagurunathan, Y., Rothberg, J. M., Sloane, B. F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2796 · Cited by 1,397 · cited 1×
“As tumor tissues have an acidic extracellular space as compared to healthy tissues , [27] in vitro release of Gem from Gem‑PEG‑GNPs was evaluated in PBS at pH 7.4 (the same as normal tissues) and pH 5.5 (the same as cancerous tissues) using dialysis tubing.”
InfluentialDendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146 · cited 1×
“[23] Considering the advantages of nanotechnology and chemoradiotherapy in combination, nanoparticles such as gold nanoparticles can be used simultaneously for drug delivery in cancer therapy and increase radiation sensitivity.”
Murdock, R. C., Braydich-Stolle, L., Schrand, A. M., Schlager, J. J., & Hussain, S. M. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm240 · Cited by 1,093 · cited 1×
“[31] The zeta potential values of the synthesized GNPs, PEG‑GNPs, and Gem‑PEG‑GNPs were determined to be ‑17.9 mV, ‑29.8 mV, and ‑19.8 mV, respectively.”
InfluentialCellular pharmacology of gemcitabine
Mini, E., Nobili, S., Caciagli, B., Landini, I., & Mazzei, T. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj941 · Cited by 842 · cited 1×
“[22] In recent years, nanocarriers have been successfully used to deliver of Gem to cancer patients.”
Radiation-Related Heart Disease: Current Knowledge and Future Prospects
Darby, S. C., Cutter, D. J., Boerma, M., Constine, L. S., Fajardo, L. F., Kodama, K., Mabuchi, K., Marks, L. B., Mettler, F. A., Pierce, L. J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.064 · Cited by 618 · cited 1×
“[36] The adverse effects of RT on healthy cells can be minimized by reducing the radiation dose while maintaining its tumor suppressive effects.”
Sarin, H. (2010) · Journal of Angiogenesis Research · doi:10.1186/2040-2384-2-14 · Cited by 562
Gold Nanoparticles for Drug Delivery and Cancer Therapy
Siddique, S., & Chow, J. C. L. (2020) · Applied Sciences · doi:10.3390/app10113824 · Cited by 446 · cited 1×
“[20] The US Food and Drug Administration (FDA) has approved gemcitabine as a standard cancer chemotherapy drug with the chemical formula C9H11F2N3O4.”
Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine
Lawrence, T. S., Chang, E. Y., Hahn, T. M., Hertel, L. W., & Shewach, D. S. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02134-5 · Cited by 308
On the Interactions of Free Radicals with Gold Nanoparticles
Zhang, Z., Berg, A., Levanon, H., Fessenden, R. W., & Meisel, D. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034830z · Cited by 272 · cited 4×
“[9] [10–12] In elements with high atomic number such as gold, X‑ray energy is effectively absorbed and deposited locally, mainly by the emission of photoelectrons, Compton scattering, and Auger electrons.”
InfluentialShewach, D. S., Hahn, T. M., Chang, E., Hertel, L. W., & Lawrence, T. S. (1994) · PubMed · Cited by 228
Prognosis of the upper limb following surgery and radiation for breast cancer
Lee, T. S., Kilbreath, S. L., Refshauge, K. M., Herbert, R. D., & Beith, J. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9710-9 · Cited by 225 · cited 1×
“[35] Also, radiation therapy for breast cancer increases the risk of death due to heart diseases.”
Growth of Gold Nanoparticles in Human Cells
Anshup, Venkataraman, J. S., Subramaniam, C., Kumar, R. R., Priya, S., Kumar, T. R. S., Omkumar, R. V., John, A., & Pradeep, T. (2005) · Langmuir · doi:10.1021/la0519249 · Cited by 191 · cited 1×
“[26]”
Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy
Huang, H., Liu, R., Yang, J., Dai, J., Fan, S., Pi, J., Wei, Y., & Guo, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071868 · Cited by 187 · cited 1×
“[16] 17–19] Based on the promising results obtained and foreseeable results in the future, it is certain that gold nanoparticles will play an important role in biomedicine, especially in drug delivery and cancer treatment.”
Gold Nanoparticles as a Potent Radiosensitizer: A Transdisciplinary Approach from Physics to Patient
Penninckx, S., Heuskin, A.-C., Michiels, C., & Lucas, S. (2020) · Cancers · doi:10.3390/cancers12082021 · Cited by 181 · cited 1×
“[9] [10–12] In elements with high atomic number such as gold, X‑ray energy is effectively absorbed and deposited locally, mainly by the emission of photoelectrons, Compton scattering, and Auger electrons.”
Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles
Lukianova-Hleb, E. Y., Kim, Y.-S., Belatsarkouski, I., Gillenwater, A. M., O'Neill, B. E., & Lapotko, D. O. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.343 · Cited by 178 · cited 1×
“[24,25] In the present study, a set of combined Gem and gold nanoparticles has been developed as a chemoradiotherapy sensitizer, and after that, the effectiveness of this sensitizer has been evaluated through in vitro experiments.”
Muriithi, W., Wanjiku Macharia, L., Pilotto Heming, C., Lima Echevarria, J., Nyachieo, A., Niemeyer Filho, P., & Moura Neto, V. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0284 · Cited by 169 · cited 1×
“[6,7] Clinical studies have shown convincing findings that concurrent chemotherapy and radiotherapy significantly improved treatment outcomes so that local tumor control is more effective and the chance survival rate is increased in patients with different types of cancer compared to the…”
McGinn, C. J., Shewach, D. S., & Lawrence, T. S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1193 · Cited by 165
The Influence of Energy Absorption and Electron Range on Dosage in Irradiated Bone
Spiers, F. W. (1949) · British Journal of Radiology · doi:10.1259/0007-1285-22-261-521 · Cited by 153 · cited 1×
“[13] Due to this increased absorption of X‑rays, harmful species for cells such as low‑energy electrons (LEE) and reactive oxygen species (ROS) are produced.”
van Vlerken, L. E., Duan, Z., Little, S. R., Seiden, M. V., & Amiji, M. M. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800030k · Cited by 152 · cited 1×
“[50] Openings in the tumor vessels may be hundreds of nanometers in size, in contrast to openings in the normal vessel walls, which are less than 10 nanometers in size.”
Selvaraj, V., & Alagar, M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.027 · Cited by 141 · cited 1×
“This new peak appeared due to the aggregation of Gem on PEG‑GNPs. [29,30] FTIR spectra of Gem and Gem‑PEG‑GNPs are illustrated in Figure 3.”
Iodine Contrast Medium Sensitizes Cultured Mammalian Cells to X Rays but Not to γ Rays
Matsudaira, H., Ueno, A. M., & Furuno, I. (1980) · Radiation Research · doi:10.2307/3575225 · Cited by 137 · cited 1×
“[40] 44] However, there is insufficient evidence to verify radiosensitivity mechanism of gemcitabine.”
Chen, S.-W., Lin, L.-C., Kuo, Y.-C., Liang, J., Kuo, C., & Chiou, J.-F. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.01.017 · Cited by 129
Huang, H., Feng, Y., Wan, T., Zhang, Y., Cao, X., Huang, Y., Xiong, Y., Huang, X., Zheng, M. H., Li, Y., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.7168 · Cited by 124 · cited 1×
“[8] However, due to the poor targeting of chemotherapy drugs and their side effects and the limitations of radiation dose tolerance in the organs, their use has faced problems in some cases.”
Remotely Triggered Nano-Theranostics For Cancer Applications
Sneider, A., VanDyke, D., Paliwal, S., & Rai, P. (2016) · Nanotheranostics · doi:10.7150/ntno.17109 · Cited by 111 · cited 1×
“[24,25] In the present study, a set of combined Gem and gold nanoparticles has been developed as a chemoradiotherapy sensitizer, and after that, the effectiveness of this sensitizer has been evaluated through in vitro experiments.”
Magnetic graphene oxide as a carrier for targeted delivery of chemotherapy drugs in cancer therapy
Huang, Y., Lin, Y.-J., & Chen, J. (2016) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2016.10.042 · Cited by 102
Nanotechnology, A Tool for Diagnostics and Treatment of Cancer
Nasır, A., Khan, A. S., Li, J., Naeem, M., Khalil, A. A. K., Khan, K. A., & Qasim, M. H. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666210701144124 · Cited by 97 · cited 1×
“[6,7] Clinical studies have shown convincing findings that concurrent chemotherapy and radiotherapy significantly improved treatment outcomes so that local tumor control is more effective and the chance survival rate is increased in patients with different types of cancer compared to the…”
Beletsi, A., Leontiadis, L., Klepetsanis, P. G., Ithakissios, D. S., & Avgoustakis, K. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00058-7 · Cited by 96
Magnetic hydrophilic methacrylate-based polymer microspheres for genomic DNA isolation
Křížová, J., Španová, A., Rittich, B., & Horák, D. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2004.12.014 · Cited by 95
Mechanisms of nanoparticle radiosensitization
Kempson, I. M. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1656 · Cited by 83 · cited 1×
“[5] In the case of chemotherapy, due to drug resistance and repeated use, significant side effects have been reported as a result of the accumulation of anticancer chemicals in healthy tissues.”
Fields, M. T., Eisbruch, A., Normolle, D. P., Orfali, A., Davis, M. A., Pu, A. T., & Lawrence, T. S. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00447-8 · Cited by 80 · cited 1×
“[40] 44] However, there is insufficient evidence to verify radiosensitivity mechanism of gemcitabine.”
Beik, J., Shiran, M. B., Abed, Z., Shiri, I., Ghadimi‐Daresajini, A., Farkhondeh, F., Ghaznavi, H., & Shakeri‐Zadeh, A. (2018) · Medical Physics · doi:10.1002/mp.13100 · Cited by 72
Smart Nanoparticles for Chemo-Based Combinational Therapy
Shrestha, B., Wang, L., Brey, E. M., Romero, G., & Tang, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060853 · Cited by 61 · cited 2×
“[39] In this study, the capacity of PEG‑Gold nanoparticles conjugated with gemcitabine as drug‑carrying nanoparticles as well as radiosensitizer in radiotherapy to optimize the lethal effect of the chemical agent against breast cancer cells (MCF‑7) has been investigated.”
Zheng, Y., & Sanche, L. (2013) · Reviews in Nanoscience and Nanotechnology · doi:10.1166/rnn.2013.1022 · Cited by 41 · cited 1×
“[14,15] Apart from these cases, gold nanoparticles have also received great attention in oncology due to their high biocompatibility, adjustable surface shape and size, and ease of distribution in extracellular fluid.”
Bemidinezhad, A., Mirzavi, F., Gholamhosseinian, H., Gheybi, F., & Soukhtanloo, M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121495 · Cited by 40
Qaddoori, M. H., & Al-Shmgani, H. S. (2023) · International Journal of Breast Cancer · doi:10.1155/2023/3251211 · Cited by 33 · cited 1×
“[16] 17–19] Based on the promising results obtained and foreseeable results in the future, it is certain that gold nanoparticles will play an important role in biomedicine, especially in drug delivery and cancer treatment.”
Menon, S. K., Mistry, B. R., Joshi, K. V., Sutariya, P. G., & Patel, R. V. (2012) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2012.02.061 · Cited by 30 · cited 1×
“[28] Based on Figure 1c, as a result of the interaction between Gem and PEG‑GNPs, the absorption peak intensity of both decreased and another peak at 596 nm was observed.”
Ribeiro, T. B., Ribeiro, A., Rodrigues, L., Harada, G., & Nobre, M. R. C. (2019) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462319000813 · Cited by 28 · cited 1×
“[21] When gemcitabine (Gem) enters cells, deoxycytidine kinase phosphorylates Gem into Gem monophosphate, which is then converted to Gem diphosphate and triphosphate.”
Analytical detection and biological assay of antileukemic drug using gold nanoparticles
Selvaraj, V., Alagar, M., & Hamerton, I. (2006) · Electrochimica Acta · doi:10.1016/j.electacta.2006.07.016 · Cited by 26 · cited 1×
“This new peak appeared due to the aggregation of Gem on PEG‑GNPs. [29,30] FTIR spectra of Gem and Gem‑PEG‑GNPs are illustrated in Figure 3.”
Chakraborty, K., Biswas, A., Mishra, S., Mallick, A. M., Tripathi, A., Jan, S., & Roy, R. S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00726 · Cited by 22
Progress against Rare and Not-So-Rare Cancers
Chabner, B. A., & Friedman, M. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260811 · Cited by 21 · cited 1×
“[34] For instance, surgery and radiotherapy can cause limitation of arm and shoulder movement, pain, and lymphedema.”
The Golden Liposomes: Preparation and Biomedical Applications of Gold-Liposome Nanocomposites
Idoudi, S., Ismail, R., Rachid, O., Elhissi, A. M. A., & Alkilany, A. M. (2023) · Journal of Nanotheranostics · doi:10.3390/jnt4030010 · Cited by 19 · cited 1×
“[16] 17–19] Based on the promising results obtained and foreseeable results in the future, it is certain that gold nanoparticles will play an important role in biomedicine, especially in drug delivery and cancer treatment.”
Hamzian, N., Hashemi, M., Ghorbani, M., Aledavood, S. A., Ramezani, M., & Toosi, M. H. B. (2019) · PubMed Central · doi:10.22037/ijpr.2019.14050.12131 · Cited by 16 · cited 1×
“[45] Compared to PEG‑Gem‑GNPs, MTT and flow cytometry [Figures 8 and 9] showed that gemcitabine was less toxic.”
Qiao, K., Mo, J., You, P., Zhang, S., Jiang, C., Lyu, M., Cui, Y., Huang, Y., & Ning, S. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02806a · Cited by 10 · cited 1×
“[9] [10–12] In elements with high atomic number such as gold, X‑ray energy is effectively absorbed and deposited locally, mainly by the emission of photoelectrons, Compton scattering, and Auger electrons.”
Hendi, N., Shakeri‐Zadeh, A., Attaran, N., Alamzadeh, Z., & Asefnejad, A. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666201218114617 · Cited by 8 · cited 1×
“[32]”
Research works printed but not linked: 2
- Hashemian, 2009, Folate-conjugated gold nanoparticles (synthesis, characterization and design for cancer cells nanotechnology-based targeting), Int J Nanosci Nanotechnol, 5, 25
- Hall, 2006, Clinical reponse of normal tissues, Radiobiology for the Radiologist., 327
Cited by
Emerging nanocarriers designed for the enhanced delivery of doxorubicin
Kong, W., Chen, W., Hui, J., & Qiu, L. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2523234 · Cited by 9
Al-Abdulhadi, S., Majeed, A. A., Polatova, D., Suliman, M., PadmaPriya, G., Karthikeyan, J., Arora, V., Nayak, P. P., Al‐Rashidi, R. R., & Kadhum, W. R. (2026) · Biotechnology Journal · doi:10.1002/biot.70242 · Cited by 1
“Pentamidine, an antimicrobial medication, combined with AuNPs increased radiosensitization in TNBC cells [49], whereas photothermal or radio-photodynamic therapy [50], and gemcitabine-loaded PEG AuNPs [51],yieldedsynergisticcelldeath,apoptosis,andROSgeneration.”
Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
“These platforms typically incorporate catalytic components, including manganese, iron, or copper-containing materials, that exploit endogenous hydrogen peroxide within the tumor microenvironment to generate highly reactive hydroxyl radicals through Fenton or Fenton-like reactions [87,90].”
InfluentialCelikkaya, S. I., Celikkaya, B. C., Hoskins, C., Akkaya, R., & Akkaya, B. (2026) · Journal of Polymers and the Environment · doi:10.1007/s10924-026-03981-6
Yang, L., Song, X., & Wang, Z. (2026) · Molecules · doi:10.3390/molecules31213895
Metadata
- Authors
- Salarvand, A., Shanei, A., Hejazi, S. H., Abedi, I., & Kakhki, N. A.
- Affiliations
- Isfahan University of Medical Sciences (IR)
- Department of Medical Nanotechnology, Science and Research Branch, Islamic Azad University, Tehran, Iran
- Corresponding author
- Shanei, Ahmad
- Venue
- Advanced Biomedical Research
- Published
- 2025-02
- Volume
- 14
- Issue
- 1
- Pages
- 12-12
- ISSN
- 2277-9175 (ISSN-L)
- PMC
- PMC11981182
- OpenAlex
- W4408021585
- Cited by
- 5
- References
- 49
- Citations by year
- 2026: 4 · 2025: 1
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Advanced Biomedical Research (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- PEGylated gold nanoparticles, gemcitabine, chemoradiotherapy, radiosensitization, breast cancer, MCF-7 cells, X-ray irradiation, apoptosis, drug synergy, nanocarriers, drug delivery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.